ACE2 and COVID-19: Paradoxically, though the levels of ACE2 expression decline in aging [49], increased COVID-19 severity was noted in older patient populations, such as that of Italy’s [2], supporting the contention that ACE2 is not the sole gateway for entry of SARS-CoV-2 [1].